View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Market Data
March 3, 2014

Covidien closes acquisition of Given Imaging

Medical devices manufacturer Covidien has closed its $860m buyout of the Israeli company Given Imaging, providing the company additional scale and scope to serve a significant medical specialty in the multibillion dollar global gastrointestinal (GI) market.

pillcam

Medical devices manufacturer Covidien has closed its $860m buyout of the Israeli company Given Imaging, providing the company additional scale and scope to serve a significant medical specialty in the multibillion dollar global gastrointestinal (GI) market.

Free Report
img

Build resilience in the face of COVID-19 disruption

COVID-19 has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities. Are you interested in actionable insights on the business challenges induced by the pandemic? GlobalData's cross-sector report analyzes the significance of this major disruptive theme across industry verticals. It provides side-by-side research of alternative datasets to present you with unique quantitative analysis of the effects of COVID-19 and how these differ across sectors. Additionally, it offers qualitative analysis of each sector and analyzes COVID-19’s impact on leading companies. Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today.
by GlobalData
Enter your details here to receive your free Report.

This acquisition boosts the company’s strategy to comprehensively address key global specialties and procedures.

Under terms of the agreement, Covidien has acquired all outstanding Given shares for $30 per share or an aggregate consideration of approximately $860m, net of cash and short-term investments acquired.

Covidien Medical Devices & US group president Bryan Hanson said: "We are committed to providing clinicians with more accurate and efficient diagnostic technologies to help achieve better outcomes for patients."

Covidien said that Given Imaging’s technology now gives it one of the broadest portfolios for visualising, monitoring and detecting abnormalities in the digestive system.

"We are committed to providing clinicians with more accurate and efficient diagnostic technologies."

The company’s broad portfolio includes the PillCam, a minimally invasive, non-sedation, swallowed optical endoscopy technology for the small bowel, esophagus and colon.

In total, Given Imaging has seven product lines across 21 GI disease states and also offers industry-leading GI functional diagnostic solutions including ManoScan high-resolution manometry, Bravo capsule-based pH monitoring, Digitrapper pH-Z monitoring and SmartPill motility monitoring systems.

Covidien will report the Given Imaging business within the Advanced Surgical revenue reporting line and the company expects Given Imaging will add between $40 and $50m per quarter in incremental revenue.

In 2012, Covidien acquired three Israeli medical device companies- respiratory monitor developer Oridion for $346m, bronchial tubes endoscope maker superDimension for $300m, and hernia mesh company PolyTouch for $40m.

According to GlobalData estimates, the endoscopy visualisation systems market in the US was valued at $463m in 2012 and is expected to grow at a CAGR of 4.2% to reach $616m by 2019.


Image: PillCam Colon video capsule. Photo: courtesy of Business Wire/ Covidien plc.

Related Companies

Free Report
img

Build resilience in the face of COVID-19 disruption

COVID-19 has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities. Are you interested in actionable insights on the business challenges induced by the pandemic? GlobalData's cross-sector report analyzes the significance of this major disruptive theme across industry verticals. It provides side-by-side research of alternative datasets to present you with unique quantitative analysis of the effects of COVID-19 and how these differ across sectors. Additionally, it offers qualitative analysis of each sector and analyzes COVID-19’s impact on leading companies. Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network